Candriam SCA’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-55,000
Closed -$5.37M 687
2015
Q1
$5.37M Buy
55,000
+15,000
+38% +$1.46M 0.11% 242
2014
Q4
$3.71M Buy
+40,000
New +$3.71M 0.08% 284